Stem Cells and MS, Collaboration is Key
How funders, researchers and clinicians come together
How funders, researchers and clinicians come together
Fatigue is one of the symptoms people with MS commonly experience, and for some, it’s the symptom that affects them the most. While the experience of fatigue varies from person to person, the effects can be felt both mentally and physically, leading fatigue to impact on daily life.
The Multiple Sclerosis International Federation (MSIF) has published the results of its ‘Is it MS?’ survey. The survey was carried out in early 2012 with over 4000 people taking part, sharing their experience of being diagnosed with MS.
For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).
© 2010 - 2025 Multiple Sclerosis Society of Ireland